Artificial intelligence is able to identify women who have an elevated risk of developing breast cancer several years before it is diagnosed, the Norwegian Institute of Public Health (FHI ...
The new report is intended to provide an update on the progress of the WHO effort, called the Global Breast Cancer Initiative, which launched in 2021. For the study, researchers analyzed an ...
Many are caused by preventable risk factors such as smoking and obesity. The Cancer in the UK 2025 report calculated additional deaths by assessing how many fewer deaths there would be if ...
Researchers have developed a computer model to help scientists identify tumor-fighting immune cells in patients with lung cancer treated with immune checkpoint inhibitors. Researchers at the Johns ...
Ireland has the second-highest rate of new cancer diagnoses in the EU, according to a report published by the European Commission. The Irish Cancer Society referred to a profile of cancer in ...
Stanford Medicine researchers sifted through thousands of single nucleotide mutations in DNA to identify fewer than 400 that are functionally associated with inherited cancer risk. Thousands of ...
Researchers at the Johns Hopkins Kimmel Cancer Center and Bloomberg~Kimmel Institute for Cancer Immunotherapy have developed a computer model to help scientists identify tumor-fighting immune ...
CINCINNATI (WKRC)— A new report from the American Cancer Society highlights significant racial disparities in cancer death rates, particularly affecting African American communities. While ...
A five-factor model effectively stratified patients with breast cancer based on lymphedema risk ... Additionally, this tool can be used to identify high-risk patients for potential new clinical ...
In the meantime, the team is working to develop a clinical test that uses multispectral immunofluorescence panels to identify the three-gene signature of immune therapy responding T cells. "We ...
Rabbit Monoclonal Primary Antibody* to identify patients with HR-positive, HER2-ultralow metastatic breast cancer who may be eligible for treatment with ENHERTU®. ENHERTU is a specifically ...